The goal: To analyze the topical problems in the use of the newest antibiotics in abdominal surgical interventions and approaches to their solution. Material and methods: The large-scale (as a rule) publications mostly of 2019–2023 on the issue were analyzed. The searching had been executed according to keywords in Pubmed (ncbi.nlm.nih.gov). Findings: Modern protected cephalosporins and carbapenems, as well as eravacycline, appear to be valuable tools in the treatment of surgical intra-abdominal infection, caused in particular by resistant microflora, especially when taking into account local data. The value of tigecycline in this nosology seems less obvious.
No takes yet. Share an insight, caveat, or question.
Ortenberg et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: